The report predicts a 7% growth between 2024 and 2025 – with $180 million in estimated payments in 2024 and $193 million in 2025.
Colonoscopy and biopsy and colonoscopy with lesion removal are also slated for a 4% increase from 2024 to 2025.
A single or multiple esophagogastroduodenoscopy biopsy is one of the fastest-growing ASC procedures, according to VMG Health’s “ASCs in 2024: A Year in Review” report.
The report predicts a 7% growth between 2024 and 2025 – with $180 million in estimated payments in 2024 and $193 million in 2025.
Colonoscopy and biopsy and colonoscopy with lesion removal are also slated for a 4% increase from 2024 to 2025.